GL1X · GenesisL1 explorer

Research workbench

B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor

Analyse B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4CQE
Type
protein
Length
498 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.3
Source
HOMO SAPIENS
Molecule
SLC45A3-braf fusion protein
UniProt
D7PBN4
Ligands
CQE
Pockets
7 · best druggability 0.66

Structure

x-ray diffraction · resolution 2.3 · 2 distinct chains · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASLC45A3-braf fusion proteinprotein25041% helix, 16% strandD7PBN4
BSLC45A3-braf fusion proteinprotein24843% helix, 14% strandD7PBN4

Ligands and binding sites

  • CQE · N-{4-[2-(1-cyclopropylpiperidin-4-yl)-4-(3-{[(2,5-difluorophenyl)sulfonyl]amino}-2-fluorophenyl)-1,3-thiazol-5-yl]pyridin-2-yl}acetamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12610.660.8232CQE
2650.640.9320empty
32620.630.8136CQE
41060.550.8418empty
51120.530.8322empty

Interfaces

1 interface between chains.

  • A–B · 1225 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 4CQE · B-RAF kinase V600E mutant in complex with a diarylthiazole B-RAF inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.